Biblio Discovery — Demo Discovery Service

5 hasil untuk "Ajantha Solomon"

Menampilkan 1–5 · 0,39 detik · RSS

  1. Artikel Jurnal Teks lengkap

    No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial

    Ajantha Solomon; Surekha Tennakoon; Edwin Leeansyah dkk.

    PLoS ONE, Vol. 9 No. 11 · 2014 · Inggris · PLOS Scopus

    Objective: To determine whether nucleos(t)ide reverse transcriptase inhibitors (NRTI) contribute to an accelerated loss in telomere length (TL) in HIV-infected patients on antiretroviral therapy (ART). Design: Substudy of randomised controlled trial. Methods: Patients with HIV RNA

  2. Artikel Jurnal Teks lengkap

    Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro

    Jenny L. Anderson; Talia M. Mota; Vanessa A. Evans dkk.

    PLOS ONE, Vol. 11 No. 7 · 2016 · Inggris · PLOS Scopus

    Developing robust in vitro models of HIV latency is needed to better understand how latency is established, maintained and reversed. In this study, we examined the effects of donor variability, HIV titre and co-receptor usage on establishing HIV latency in vitro using two models of HIV latency…

  3. Artikel Jurnal Teks lengkap

    The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir

    Youry Kim; Jenny L. Anderson; Carolin Tumpach dkk.

    PLOS Pathogens, Vol. 22 No. 1 · 2026 · Inggris · PLOS Scopus

    The persistence of latently infected CD4 + T-cells in people with HIV (PWH) on suppressive antiretroviral therapy (ART) is the major barrier to an HIV cure. We investigated the impact of two classes of pro-apoptotic drugs, phosphoinositide-3 kinases (PI3K) inhibitors or the B cell lymphoma 2…

  4. Artikel Jurnal Teks lengkap

    Diverse effects of interferon alpha on the establishment and reversal of HIV latency

    Renée M. Van der Sluis; Jennifer M. Zerbato; Jake W. Rhodes dkk.

    PLOS Pathogens, Vol. 16 No. 2 · 2020 · Inggris · PLOS Scopus

    HIV latency is the major barrier to a cure for people living with HIV (PLWH) on antiretroviral therapy (ART) because the virus persists in long-lived non-proliferating and proliferating latently infected CD4+ T cells. Latently infected CD4+ T cells do not express viral proteins and are therefore…

  5. Artikel Jurnal Teks lengkap

    Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy

    Julian H. Elliott; Fiona Wightman; Ajantha Solomon dkk.

    PLoS Pathogens, Vol. 10 No. 11 · 2014 · Inggris · PLOS Scopus

    : Human immunodeficiency virus (HIV) persistence in latently infected resting memory CD4+ T-cells is the major barrier to HIV cure. Cellular histone deacetylases (HDACs) are important in maintaining HIV latency and histone deacetylase inhibitors (HDACi) may reverse latency by activating HIV…